Varenicline, a smoking cessation drug, inhibits formation of abdominal aortic aneurysm via α7 nicotinic acetylcholine receptors.

○Koshun Inada

[30P-am218] Varenicline, a smoking cessation drug, inhibits formation of abdominal aortic aneurysm via α7 nicotinic acetylcholine receptors.

○Koshun Inada¹, Mitsuhisa Koga², Ayano Yamada², Atsushi Yamauchi¹ (1. Dept. Pharmaceut. Care and Health Sci., Fac. Pharmaceut. Sci., Fukuoka Univ., 2. Dept. Drug Delivery, Fac. Pharmaceut. Sci., Fukuoka Univ.)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[30P-am] Pharmacology 3

[30P-am218] Varenicline, a smoking cessation drug, inhibits formation of abdominal aortic aneurysm via α7 nicotinic acetylcholine receptors.

Password